NCT01135940

Brief Summary

This is a prospective, Phase II (hypothesis generating) randomized pilot study investigating the efficacy of using Dermabond as a method of final wound closure as compared to the standard staple method in children with Neuromuscular Scoliosis undergoing spinal deformity correction surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started May 2010

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 1, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2010

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

June 1, 2016

Status Verified

May 1, 2016

Enrollment Period

6.1 years

First QC Date

June 1, 2010

Last Update Submit

May 30, 2016

Conditions

Keywords

neuromuscular scoliosisdermabondinfectionwound closure

Outcome Measures

Primary Outcomes (1)

  • Difference in the incidence of wound infection in Dermabond group versus the skin staple group

    To explore whether there is a difference in the incidence of wound infection in Dermabond group versus the skin staple group as measured by microbiological culture taken 4 days post-operatively. Wound infection is defined as prolonged sterile discharge , positive wound cultures, or cellulitis four or more days post-operatively.

    12 weeks after surgery

Secondary Outcomes (3)

  • Difference in the cosmetic result of the wound closure as measured by the Hollander wound evaluation scale

    12 weeks after surgery

  • Difference in the time for final wound closure

    Day of surgery

  • Difference in mean caregiver/parental satisfaction scores as measured by a visual analog scale

    12 weeks after surgery

Study Arms (2)

1

EXPERIMENTAL

2-octylcyanoacrylate (Dermabond) closure

Device: 2-octylcyanoacrylate (Dermabond) closure

2

ACTIVE COMPARATOR

Standard staple closure

Device: Standard staple closure

Interventions

Standard procedure for closure of adipose/ subcutaneous layers. The subcuticular layer will be closed with a continuous 2-0 vicryl suture which will then be followed by Dermabond closure.

1

Standard procedure for closure of adipose/ subcutaneous layers followed by staple closure

2

Eligibility Criteria

AgeUp to 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • male or female 19 years or younger
  • neuromuscular scoliosis
  • undergoing posterior spinal instrumentation and fusion (one stage)

You may not qualify if:

  • other non-neuromuscular causes of scoliosis
  • previous history of spinal surgery
  • previous incision over the operative site
  • history of keloid formation
  • allergy to superglue
  • use of anticoagulation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

British Columbia Children's Hospital Department of Orthopaedics

Vancouver, British Columbia, V6H 3V4, Canada

RECRUITING

MeSH Terms

Conditions

Wounds and InjuriesInfections

Study Officials

  • Firoz Miyanji, MD, FRCSC

    University of British Columbia

    PRINCIPAL INVESTIGATOR
  • Christopher W. Reilly, MD, FRCSC

    University of British Columbia

    STUDY DIRECTOR
  • Kishore Mulpuri, MBBS, MS

    University of British Columbia

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2010

First Posted

June 3, 2010

Study Start

May 1, 2010

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

June 1, 2016

Record last verified: 2016-05

Locations